S. R. Schill & Associates Johnson & Johnson Transaction History

S. R. Schill & Associates

$228 Million
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 04, 2024	SELL	$155.22 - $162.74 $61,467 - $64,445	-396 Reduced 11.8%	2,959 $468,000
Q4 2023 Jan 29, 2024	SELL	$145.6 - $158.88 $145 - $158	-1 Reduced 0.03%	3,355 $525,000
Q3 2023 Oct 24, 2023	SELL	$155.75 - $174.48 $16,821 - $18,843	-108 Reduced 3.12%	3,356 $522,000
Q2 2023 Aug 03, 2023	SELL	$154.35 - $166.11 $191,702 - $206,308	-1,242 Reduced 26.39%	3,464 $573,000
Q1 2023 Apr 26, 2023	SELL	$151.05 - $180.26 $150,294 - $179,358	-995 Reduced 17.45%	4,706 $729,000
Q4 2022 Jan 25, 2023	BUY	$160.2 - $179.79 $54,307 - $60,948	339 Added 6.32%	5,701 $0
Q3 2022 Oct 26, 2022	SELL	$161.33 - $179.52 $192,305 - $213,987	-1,192 Reduced 18.19%	5,362 $876,000
Q2 2022 Aug 31, 2022	BUY	$168.19 - $186.01 $44,570 - $49,292	265 Added 4.21%	6,554 $1.16 Million
Q1 2022 May 06, 2022	BUY	$158.14 - $179.59 $31,153 - $35,379	197 Added 3.23%	6,289 $1.12 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $563,686 - $625,431	-3,615 Reduced 37.24%	6,092 $1.04 Million
Q3 2021 Oct 25, 2021	SELL	$161.5 - $179.47 $135,660 - $150,754	-840 Reduced 7.96%	9,707 $1.57 Million
Q2 2021 Aug 17, 2021	BUY	$159.48 - $171.07 $30,460 - $32,674	191 Added 1.84%	10,547 $1.74 Million
Q1 2021 Apr 30, 2021	BUY	$153.07 - $170.48 $45,308 - $50,462	296 Added 2.94%	10,356 $1.7 Million
Q4 2020 Jan 27, 2021	SELL	$137.11 - $157.38 $332,080 - $381,174	-2,422 Reduced 19.4%	10,060 $1.58 Million
Q3 2020 Nov 18, 2020	SELL	$140.38 - $153.83 $73,137 - $80,145	-521 Reduced 4.01%	12,482 $1.86 Million
Q2 2020 Jul 30, 2020	SELL	$128.81 - $155.51 $231,085 - $278,984	-1,794 Reduced 12.12%	13,003 $1.83 Million
Q1 2020 May 04, 2020	BUY	$111.14 - $153.99 $338,977 - $469,669	3,050 Added 25.96%	14,797 $1.94 Million
Q4 2019 Feb 04, 2020	BUY	$127.5 - $146.44 $6,375 - $7,322	50 Added 0.43%	11,747 $1.71 Million
Q3 2019 Oct 24, 2019	SELL	$126.95 - $142.14 $248,441 - $278,167	-1,957 Reduced 14.33%	11,697 $1.51 Million
Q2 2019 Aug 19, 2019	BUY	$131.15 - $144.24 $12,590 - $13,847	96 Added 0.71%	13,654 $1.9 Million
Q1 2019 May 02, 2019	SELL	$125.72 - $139.79 $64,745 - $71,991	-515 Reduced 3.66%	13,558 $1.9 Million
Q4 2018 Jan 24, 2019	BUY	$122.84 - $147.84 $31,692 - $38,142	258 Added 1.87%	14,073 $1.82 Million
Q3 2018 Oct 30, 2018	BUY	$121.58 - $142.88 $350,758 - $412,208	2,885 Added 26.4%	13,815 $1.91 Million
Q2 2018 Jul 26, 2018	BUY	$119.4 - $131.76 $26,745 - $29,514	224 Added 2.09%	10,930 $1.33 Million
Q1 2018 May 10, 2018	SELL	$125.1 - $148.14 $5,254 - $6,221	-42 Reduced 0.39%	10,706 $1.37 Million
Q4 2017 Feb 05, 2018	BUY	$131.22 - $143.62 $28,081 - $30,734	214 Added 2.03%	10,748 $1.5 Million
Q3 2017 Nov 02, 2017	BUY	$129.47 - $135.38 $1.36 Million - $1.43 Million	10,534	10,534 $1.37 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of S. R. Schill & Associates, based on Form 13F filings with the SEC.

News

Stay updated on S. R. Schill & Associates with notifications on news.

Account